CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,253,826
- in 9 filings, $2.1M under 10b5-1 plans
Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-01 | Welgus Howard G. Director | Exercise or conversion | +556 | $0.58 | $323 | 182,452 |
| 2021-09-01 | Welgus Howard G. Director | Exercise or conversion | +4,444 | $1.68 | $7K | 186,896 |
| 2021-09-01 | Welgus Howard G. Director | Sale | −4,200 | $20.71 | $87K | 182,696 |
| 2021-09-01 | Welgus Howard G. Director | Sale | −800 | $21.28 | $17K | 181,896 |
| 2021-09-01 | Welgus Howard G. Director | Exercise or conversion · Stock Option (Right to Buy) | −556 | 25,106 | ||
| 2021-09-01 | Welgus Howard G. Director | Exercise or conversion · Stock Option (Right to Buy) | −4,444 | 9,223 | ||
| 2021-08-05 | Watanabe Todd Franklin President and CEO | Exercise or conversion | +1,000 | $1.68 | $2K | 595,779 |
| 2021-08-05 | Watanabe Todd Franklin President and CEO | Sale | −1,000 | $20.81 | $21K | 594,779 |
| 2021-08-05 | Watanabe Todd Franklin President and CEO | Exercise or conversion · Stock Option (Right to Buy) | −1,000 | 128,635 |
Page 35 of 35 · 689 trades